<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00701623</url>
  </required_header>
  <id_info>
    <org_study_id>HEPCRI0208</org_study_id>
    <nct_id>NCT00701623</nct_id>
  </id_info>
  <brief_title>Sodic Heparin Effectiveness of the Treatment of Burns</brief_title>
  <acronym>SODIC HEPARIN</acronym>
  <official_title>Clinical Efficacy of Product Alimax Â® (Sodic Heparin) in Treatment of Burns: Comparative Study of Raw Materials Between Two Suppliers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azidus Brasil</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azidus Brasil</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Burns are injuries caused by agents thermal, chemical, electrical or radioactive who act in&#xD;
      the tissue lining of the human body and may partially or totally destroy the skin and its&#xD;
      annexes, to the deeper layers, as subcutaneous tissue, muscles, tendons and bones .&#xD;
&#xD;
      Studies show that topical heparin has, in addition to the already known anticoagulant&#xD;
      activity, anti-inflammatory properties, analgesic, and neoangiogenic, stimulating blood flow&#xD;
      and increasing the repair of the fabric as well as the restoration of collagen and&#xD;
      reepiteliztion. Moreover, the use of heparin reduces the need for painful medical procedures,&#xD;
      as debridations, surgeries and transplants The intention of this work is to verify the&#xD;
      effectiveness and safety of sodium heparin in the treatment of burns of the skin.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with burns that come to the emergency room will be informed about the&#xD;
&#xD;
      Inclusion Criteria&#xD;
&#xD;
        -  Patients aged above 12 years who have suffered thermal burns of 2nd degree burns or&#xD;
           mixed 2 and 3 degrees in up to 10% of body surface and indication of outpatient&#xD;
           treatment.&#xD;
&#xD;
      Exclusion Criteria&#xD;
&#xD;
        -  Area burned more than 10% of body surface&#xD;
&#xD;
        -  the presence of the 3 rd degree burns&#xD;
&#xD;
        -  burns in the face or genitals&#xD;
&#xD;
        -  burns in poly-traumatized&#xD;
&#xD;
        -  respiratory injury&#xD;
&#xD;
        -  disorders of coagulation&#xD;
&#xD;
        -  thrombocytopenia&#xD;
&#xD;
        -  erosive gastro cases&#xD;
&#xD;
        -  clinically relevant bleeding&#xD;
&#xD;
        -  hypersensitivity to anticoagulants&#xD;
&#xD;
        -  liver disease&#xD;
&#xD;
        -  nephropathy&#xD;
&#xD;
        -  diabetes&#xD;
&#xD;
        -  35&#xD;
&#xD;
        -  serious allergy&#xD;
&#xD;
        -  descontrole emotional&#xD;
&#xD;
        -  pregnancy&#xD;
&#xD;
        -  anemia&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <start_date>June 2008</start_date>
  <primary_completion_date type="Anticipated">June 2008</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary: immediate decrease in pain. Secondary: analgesic request for 10 minutes after application of heparin, signs of intolerance and adverse events.</measure>
    <time_frame>healing</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Burns</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients treated with heparin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients treated with heparin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients treated with folder water directly on the injured area</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>heparin</intervention_name>
    <description>patients will receive the application of one of two types of heparin directly on the injured area</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>heparin</intervention_name>
    <description>patients will receive the application of one of two types of heparin directly on the injured area</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>folder water</intervention_name>
    <description>patients will receive the application of folder water directly on the injured area</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged above 12 years who have suffered thermal burns of 2nd degree burns or&#xD;
             mixed 2 and 3 degrees in up to 10% of body surface and indication of outpatient&#xD;
             treatment.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Area burned more than 10% of body surface&#xD;
&#xD;
          -  the presence of the 3 rd degree burns&#xD;
&#xD;
          -  burns in the face or genitals&#xD;
&#xD;
          -  burns in poly-traumatized&#xD;
&#xD;
          -  respiratory injury&#xD;
&#xD;
          -  disorders of coagulation&#xD;
&#xD;
          -  thrombocytopenia&#xD;
&#xD;
          -  erosive gastro cases&#xD;
&#xD;
          -  clinically relevant bleeding&#xD;
&#xD;
          -  hypersensitivity to anticoagulants&#xD;
&#xD;
          -  liver disease&#xD;
&#xD;
          -  nephropathy&#xD;
&#xD;
          -  diabetes&#xD;
&#xD;
          -  35&#xD;
&#xD;
          -  serious allergy&#xD;
&#xD;
          -  descontrole emotional&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  anemia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>LAL Clinica PPesquisa e Desenvolvimento</name>
      <address>
        <city>Valinhos</city>
        <state>Sao Paulo</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>February 2008</verification_date>
  <study_first_submitted>June 17, 2008</study_first_submitted>
  <study_first_submitted_qc>June 18, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2008</study_first_posted>
  <last_update_submitted>October 26, 2010</last_update_submitted>
  <last_update_submitted_qc>October 26, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 27, 2010</last_update_posted>
  <responsible_party>
    <name_title>Alexandre Frederico</name_title>
    <organization>LAL Clinica</organization>
  </responsible_party>
  <keyword>The intention of this work is to verify the effectiveness and safety of sodium heparin in the treatment of burns of the skin.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Burns</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heparin</mesh_term>
    <mesh_term>Calcium heparin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

